Herpesviral DNA fragments isolated from AIDS-associated Kaposi's sarcoma (KS) tissue (KSHV-DNA) share homology with two lymphotropic oncogenic ~-herpesviruses, EpsteinBarr virus and Herpesvirus saimiri, and are present in the lesions of more than 95% of HIV and non-HIV-associated forms of KS, AIDS-related body cavity-based lymphomas, and AiDS-related multicentric Castleman's disease. Here we show that BC-1, a KSHV-DNA-positive, body cavity-based lymphoma cell line, produces infective herpesviral particles carrying a linear 270-kb genome that specifically transmits KSHV-DNA to CD19 + B cells. Transmission of KSHV-DNA is dependent upon a biologically active, replicating virus, since it is blocked by UV irradiation and foscarnet, an inhibitor of viral DNA-polymerase. This study represents the first isolation and transmission of the human herpesvirus-8/KS-associated herpesvirus.
T
he herpesviruses (family Herpesviridae) are doublestranded DNA enveloped viruses widely distributed in nature that are implicated in many human diseases (1) . Herpesviral DNA fragments recently identified in AIDSassociated Kaposi's sarcoma (KS) tissue (2-4) (KS herpesviral-like DNA [KSHV-DNA]) (5) share homology with two lymphotropic oncogenic ~/-herpesviruses, EBV (6) and Herpesvirus saimiri (HVS) (7) . EBV is a B cell-immortalizing virus that is involved in the pathogenesis of malignant lymphomas (6) . HVS is a T cell-immortalizing virus that can cause fulminant T cell lymphomas (7) . The homology of KSHV-DNA with these viruses suggests that the newly identified sequences may belong to the genome of a new member of the herpesvirus family (1) . Although these sequences were first identified in KS tissue (5, 8, 9) , and more recently in other proliferative diseases (10, 11) , the role of the putative new herpesvirus in the pathogenesis of these disorders remains to be defined. Primary to this question is the isolation and characterization of the putative KSHV-DNA virus. Here we show the first isolation of infective herpesviral particles (human herpesvirus-8 [HHV-8/ KSHV]) that specifically transmit KSHV-DNA to normal circulating human B cells. E.A. Mesri dedicates this paper to his mother, Frida Schlaien (1937 Schlaien ( -1982 .
Materials and Methods
Viral Preparation. Viral pellets were obtained as described in (12) . Briefly, BC-1 cells (13) were collected at low-speed centrifugation, resuspended in 1:20 vol of media, and snap-frozen (cell-associated virus extract). To obtain supernatant virus pellets, postculture-conditioned media from BC-1 cells was cleared by centrifugation at 1,400 g 4~ filtered through a 0.45-1xm membrane and centrifuged 2 h at 23,000 g at 4~ Pellets were resuspended in 1:50 vol of media and snap-frozen in dry ice/ethanol. Both extracts (cell or supernatant virus) were thawed and frozen and thawed once more, sonicated 4 • 40 s in a cup sonicator (Heat Systems-Ultrasonics, Inc., Plainview, NY), and cleared by centrifugation at 10,000 g at 4~ To concentrate and further purify the viral preparations (14), they were loaded over a 25% sucrose/ PBS (Ca 2+, Mg 2+) cushion and pelleted by overnight centrifugation at 70,000g at 4~ Viable BC-1 cells that might contaminate the preparation were excluded by passaging through a 0.45-~m filter (supematant virus), triple freezing and thawing in the absence of freezing agents, and extensive sonication and centrifugation at 10,000 g. Furthermore, the viral isolates were examined for the presence of any contaminating cell by light and electron microscopy, by culture in rich medium, and sensitivity to DNAse degradation of the cellular genep53 (see Fig. 1 A) Southern Blot for KSHV-DNA or EBV Sequences. Gels were transferred to nitrocellulose filters and probed with random prime 32p-labeled probes for KSHV-DNA (KSBam330 fragment [5] ) or the EBV terminal repeat region (10, 13) .
PCR Detection of KSHV-DNA and p53. Cells were pelleted and resuspended in 3 jxl PBS. Resuspended cells, or viral extracts (3 ~1), were treated with 30 I*1 of Genereleaser (Bio-Ventures, Mufreesboro, TN). The DNA was released in a thermocycler following the manufacturer's protocol. Primers for KSBam 330233 or for p53 (5) were added to one third of the DNA, and a PCR reaction was carried out in a thermocycler as described (5).
DNAse Treatment of the Viral Isolates. Before PCR, viral extracts were treated with RNAse-free DNAase I (Boehringer Mannheim) for 15 rain following the manufacturer's conditions. Itfeaion Studies. Umbilical cord blood mononuclear cells (CBMC) obtained by Ficoll centrifugation were incubated for 40 rain at room temperature with viral extracts at a cell density of 107 cells/ml, washed once with media to remove excess virus, resuspended in RPMI, 20% FCS, 20% CD34-derived spindle cell (Rafii, S., E.A. Mesri, and A.S. Asch, unpublished data) conditioned media (RC-20 medium) at a density of 106 cells/m], and incubated during a week. For PCR, one-third of the cells were harvested, washed once with media, and treated with Genereleaser.
UV Irradiation of the Viral Preparations. Viral pellets resuspended in PBS or media were exposed to a dose of 9 mJ of UV light using a Stratalinker (Stratagene, La Jolla, CA).
Enrichment in CD19 Cells and Immunodepletion of CD19 Ceils. B cells were immunoselected from CBMC using an anti-CD19 mAb coupled to magnetic beads (Dynabeads; Dynal, Lake Success, NY) following the manufacturer's conditions. A similar procedure repeated three times was used to deplete the CBMC of B cells.
Effect of Foscarnet. Infected cells were incubated in the presence of different doses of Foscamet (Foscavir; Astra, Westborough, MA).
Results
We used methods for herpesviral preparation and concentration to obtain viral particles from BC-1 cells, an AIDS-related, body cavity-based lymphoma (BCBL) cell line that stably carries KSHV-DNA (13). We obtained sucrose cushion purified cell-free pellets (see Materials and Methods) that were KSHV-DNA-positive by PCI< from both BC-1 cells and their supernatants (Fig. 1 A) . KSHV-DNA present in the viral preparations within a viral capsid should be resistant to DNAse degradation, whereas free DNA should be sensitive. Fig. 1 A shows the results of the DNAse sensitivity assay of KSHV-DNA from viral isolates. As an internal control for free (nonencapsidated) DNA, we used the detection of the cellular gene p53, present in free BC-1 cellular genomic DNA which is also found in the viral preparations. When the pellets were treated with DNAse, the p53 gene could no longer be detected by PC1L. In contrast, KSHV-DNA in the viral isolates is DNAse resistant and can be amplified by PCR after DNAse treatment (Fig.  1) , indicating that the KSHV-DNA is protected, quite possibly inside a viral capsid. To show that DNAse protection of viral genes was not limited to this KSHV-DNA fragment (KS330Bam) and its immediately adjacent region, we also carried out a similar analysis with a viral gene adjacent to the other reported KSHV fragment (KS631Bam; [5] that was recently cloned and is distant from KSHV330Bam (Cesarman, E., R. Nador, and D.M. Knowles, manuscript in preparation). We found that this KSHV gene was also protected from DNAse degradation (data not shown).
To further characterize the viral preparation, we performed negative-staining electron microscopy that showed the presence of several virus-like particles (Fig. 1 B) . While none of these particles allows unequivocal identification as a herpesvirus, they have features of the herpesviruses and similarly appearing particles are characteristic of herpesviral preparations (15) . No intact cells or other cellular organelles were seen in these preparations.
PFGE of the viral preparations ( Fig. 1 C) showed that KSHV-DNA belongs to a linear 270-kb genome present both in BC-1 cells (16) and in the viral pellet. In contrast, EBV, also produced by BC-I cells (13) , hybridizes with a 170-kb genome. Our results show that in the BC-1 viral isolates, KSHV-DNA is contained in a viral genome that is distinct from the EBV genome. The DNAse protection of distant segements of the 270-kb KSHV-DNA viral genome, in contrast with the DNAse sensitivity of nonvirally associated genes and the presence of herpesviral-like particles in the isolates, are consistent with encapsidation of the KSHV-DNA viral genome.
To determine whether the virus carrying KSHV-DNA was infective, we tested the viral preparations for their capacity to infect CBMC. Fig. 2 A shows viral transmission of KSHV-DNA to CBMC after 1 wk of exposure to the viral isolates. The figure further shows that UV irradiation of the viral extracts abolishes KSHV-DNA transmission without modifying its ability to act as a PCR. template. Since this dose of UV irradiation is known to inactivate herpesviral DNA replication and transcription, our results indicate that transmission of KSHV-DNA is accomplished by transmission in an active herpesvirus, HHV-8/KSHV.
A recent report notes that KSHV-DNA is not present in AIDS-KS spindle cell lines, but is found in the CD19 B cell compartment of KS patients (17) . This finding and the fact that KSHV-DNA is present in the neoplastic cells of BCBL (10, 13) strongly suggest that HHV-8/KSHV may be a lymphotropic virus possibly targeting the B cell compartment. To establish whether HHV-8/KSHV is a B cell-specific virus, we used immunoselection techniques to positively Foscarnet is a specific inhibitor o f herpesviral D N A polymerase (18) . Its potential benefit as a therapeutic agent for A I D S -K S may be o f importance (19, 20) . T h e results in 
Discussion
O u r data demonstrate that the herpesviral D N A fragments associated with KS and B C B L are part o f a n e w transmissible B -l y m p h o t r o p i c herpesvirus. W e favor its den o m i n a t i o n as h u m a n herpesvirus-8 instead o f the former descriptive name o f Kaposi's sarcoma-associated herpesvirus (5) because it is also associated with B C B L and A I D Srelated multicentric Castleman's disease (10) . Genetic studies show that H H V -8 / K S H V is a virus o f the subfamily Gammaherpesvirinae, and it is the first h u m a n virus o f the genus Rhadinovirus (16) ; studies also show that K S H V -D N A is part o f a viral g e n o m e that is collinear to Herpesvirus saimiri (Cesarman et al., manuscript in preparation).
A l t h o u g h it has been found in a few other tumors (4, 21) , the very strong association found b e t w e e n K S H V -D N A and KS (5, 8, 9) Moreover, a recent report shows that the appearance of HHV-8-infected cells in the peripheral blood predisposes for the development of KS in HIV-infected individuals (22) . It is therefore possible that agents that can impede HHV-8/KSHV replication or infection (such as foscarnet) might be useful in preventing or ameliorating the course of these disorders (19, 20) . Our findings raise the possibility that HHV-8/KSHV-infected B cells play a role in the pathogenesis of KS. Further studies defining the biology of HHV-8/KSHV and how it can modify the phenotype of infected B cells in the context of HIV infection (3, 4, 23) would provide important insights on the pathophysiology of KS and other AIDS-associated malignancies, and they may establish the potential of HHV-8/KSHV as a therapeutic target for these disorders.
